GenScript

GenScript - Make Research Easy - The leader in molecular cloning and gene synthesis, peptide synthesis, protein and antibody engineering..

Launch date

2002

Employees

501-1000 people

Market cap

Enterprise valuation

€1.8b (Public information from Aug 2024)

Piscataway Township New Jersey (HQ)

http://genscript.com

https://twitter.com/genscript https://www.facebook.com/genscriptcorp https://www.linkedin.com/company/genscript-corporation

View job openings

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	391m	511m	626m	840m	1.3b	1.9b	2.8b
% growth	43 %	31 %	22 %	34 %	53 %	50 %	45 %
EBITDA	(174m)	(449m)	(372m)	(279m)	(199m)	75.4m	379m
% EBITDA margin	(44 %)	(88 %)	(59 %)	(33 %)	(16 %)	4 %	14 %
Profit	(205m)	(348m)	(227m)	(95.5m)	(103m)	28.0m	389m
% profit margin	(52 %)	(68 %)	(36 %)	(11 %)	(8 %)	1 %	14 %
EV / revenue	7.3x	15.8x	9.3x	6.4x	2.0x	1.4x	0.8x
EV / EBITDA	-16.4x	-17.9x	-15.7x	-19.4x	-12.8x	36.6x	6.2x
R&D budget	263m	358m	390m	433m	-	-	-
R&D % of revenue	67 %	70 %	62 %	52 %	-	-	-

Date	Investors	Amount	Round
Dec 2015	N/A	N/A	IPO
May 2021	Hillhouse Capital	$500m Valuation: $5.9b 15.1x EV/LTM Revenues -34.0x EV/LTM EBITDA	Post IPO Equity
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by GenScript Dec 2017

Jinan Nornoon Biological Engineering

ACQUISITION by GenScript Apr 2016